MSA
CMD

Marino Stram & Associates’s Cantel Medical Corporation CMD Stock Holding History

Marino Stram & Associates’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,201
Closed -$80K – 619
2019
Q1 		$80K Sell
1,201
-21
-2% -$1.59K 0.06% 134
2018
Q4 		$91K Buy
1,222
+68
+6% +$5.61K 0.08% 117
2018
Q3 		$106K Buy
1,154
+1
+0.1% +$95 0.08% 126
2018
Q2 		$113K Hold
1,153
– – 0.1% 111
2018
Q1 		$128K Buy
1,153
+1
+0.1% +$112 0.12% 98
2017
Q4 		$119K Buy
+1,152
New +$115K 0.11% 101

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Marino Stram & Associates's CMD Position: Q2 2019 in Review

Marino Stram & Associates sold out of Cantel Medical Corporation (CMD) in Q2 2019, closing a stake of 1,201 shares — an estimated $80K sold.

Marino Stram & Associates first reported a position in CMD in Q4 2017 and held it in 6 quarters. The position peaked at $128K in Q1 2018. 242 funds tracked by Wall St. Rank hold CMD as of Q2 2019.

  • Marino Stram & Associates reported no remaining Cantel Medical Corporation position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 1,201 Cantel Medical Corporation shares in Q2 2019, an estimated $80K.
  • Marino Stram & Associates first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 6 quarters.
  • Marino Stram & Associates's Cantel Medical Corporation position peaked at $128K in Q1 2018.
  • 242 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.